LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity

The National Center for Biotechnology Information

D. A. Benson, Mark S. Boguski, David J. Lipman et al. · Genomics · 1990 · 5.2K citations · Full text

Life Sciences, Biotechnology, Molecular Biology +10

Mechanisms of Lactone Hydrolysis in Neutral and Alkaline Conditions

Rafael Gómez‐Bombarelli, Emilio Calle, Julio Casado · The Journal of Organic Chemistry · 2013 · 81 citations

Natural Sciences, Biochemistry, Chemistry +17

Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries

Eloísa Rubio‐Beltrán, Ka Yi Chan, AH Jan Danser et al. · Cephalalgia · 2019 · 76 citations

Medicine, Pharmacology, Pharmacotherapy +15

Strategies To Address Mutagenic Impurities Derived from Degradation in Drug Substances and Drug Products

Mark H. Kleinman, David Elder, Andrew Teasdale et al. · Organic Process Research & Development · 2015 · 36 citations

Pharmacy, Pharmaceutical Analysis, Toxicology +17

The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7

Robert S. Foster, Adrian Fowkes, Alex Cayley et al. · Genes and Environment · 2020 · 31 citations · Full text

Pharmacy, Toxicology, Drug Design +13